Big Gain For Galectin Therapeutics, Inc.
Wed, Apr 28, 2021 at 05:30 PM
Galectin Therapeutics, Inc. (GALT:NASDAQ) shot up at $5.1, representing a gain of 22.6%. On Tue, Apr 27, 2021, GALT:NASDAQ hit a New 2-Week Intraday High of $4.41. The stock got featured on our News Catalysts scanner on Tue, Apr 27, 2021 at 10:30 AM in the 'MISCELLANEOUS' category. From Tue, Apr 13, 2021, the stock recorded 60.00% Up Days and 63.64% Green Days
About Galectin Therapeutics, Inc. (GALT:NASDAQ)
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Top 10 Gainers:
- Companhia Paranaense de Energia - COPEL (ELP:NYSE), 411.5%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 75.62%
- Uxin Limited (UXIN:NASDAQ), 45.32%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 44.77%
- U.S. Well Services, Inc. (USWS:NASDAQ), 26.65%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 22.6%
- Aurora Mobile Limited (JG:NASDAQ), 19.6%
- Millendo Therapeutics, Inc. (MLND:NASDAQ), 18.9%
- Shineco, Inc. (TYHT:NASDAQ), 17.67%
- ClearSign Technologies Corporation (CLIR:NASDAQ), 16.28%